There are 10 days left to apply for the Genome Engineer Innovation Grant being awarded by Synthego. The awards total $1 million worth of their products, which are designed to make performing CRISPR gene editing technology easier and more accessible.

“At its core, this grant is about propelling the genome engineering industry forward and cultivating the next generation of genome engineers,” Rich Stoner, PhD, the CSO of Synthego, told GEN. “We believe in the good that this technology can bring about and are committed to helping bright scientists and researchers to unlock its potential.”

Synthego’s main products are Engineered Cells, a service where Synthego delivers custom-edited gene knockout cell lines to the customer and kits such as the synthetic single guide RNAs (sgRNAs) kit and gene knockout kit that allow modification of cells in the lab. Their customers are from labs in large biotech companies to academics.

The inaugural Genome Engineer Innovation Grant is part of Synthego’s mission to make genome engineering tools accessible to all scientists. Among the applicants, Synthego will look for scientists working on novel research or interesting applications of genome engineering and have a need for financial assistance.

“We’re investing $1 million in the future of genome engineering because we believe CRISPR—and the genome engineers who use it—are poised to uncover unprecedented scientific breakthroughs and change the way we tackle humanity’s biggest challenges,” said Stoner. “We want to help bring standards and protocols to genome engineering by providing the next generation of industry leaders with the tools they need to achieve results and bring life-changing cures to people faster.”

For the grant, Synthego will distribute the $1,000,000 in multiple grants, based on merit. Award amounts will vary based on the Synthego product chosen for the particular grant award. The deadline to apply is March 29, 2019, at 11:59 PM PST and winners will be announced on April 19, 2019.

Previous articleIsrael’s Sheba Medical Center to Manufacture Cell Therapies Using Lonza’s Cocoon Platform
Next articleEpigenetic Marks on Sperm Chromosomes Impact Gene Expression in Offspring